Skip to main content
Log in

Microangiopathy without hemolysis in a patient following allogeneic bone marrow transplantation

  • Case Report
  • Published:
Bone Marrow Transplantation Submit manuscript

Abstract

Thrombotic microangiopathy (TMA) is one of the complications of bone marrow transplantation (BMT) which includes hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP). Red cell fragmentation is the most consistent laboratory finding. We present a case of TMA with endothelial damage but without the signs of hemolysis. The patient was not receiving cyclosporine. Partial activation of platelets was also observed. This case represents a new form of TMA in transplant recipients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akiyama, H., Yoshinaga, H., Endou, M. et al. Microangiopathy without hemolysis in a patient following allogeneic bone marrow transplantation. Bone Marrow Transplant 20, 261–263 (1997). https://doi.org/10.1038/sj.bmt.1700875

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1700875

  • Springer Nature Limited

Keywords

This article is cited by

Navigation